ETIMX
Price
$14.99
Change
-$0.09 (-0.60%)
Updated
Sep 12 closing price
Net Assets
388.86M
RLBEX
Price
$38.53
Change
-$0.06 (-0.16%)
Updated
Sep 12 closing price
Net Assets
262.26B
Interact to see
Advertisement

ETIMX vs RLBEX

Header iconETIMX vs RLBEX Comparison
Open Charts ETIMX vs RLBEXBanner chart's image
Eventide Balanced Fund
Price$14.99
Change-$0.09 (-0.60%)
VolumeN/A
Net Assets388.86M
American Funds American Balanced R4
Price$38.53
Change-$0.06 (-0.16%)
VolumeN/A
Net Assets262.26B
ETIMX vs RLBEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETIMX vs. RLBEX commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETIMX is a Hold and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 262B vs. ETIMX (389M). ETIMX pays higher dividends than RLBEX: ETIMX (2.03) vs RLBEX (1.79). ETIMX was incepted earlier than RLBEX: ETIMX (10 years) vs RLBEX (23 years). ETIMX (0.89) is less costly to investors than RLBEX (0.59). RLBEX (44.00) and ETIMX (43.00) have comparable annual turnover. RLBEX has a lower initial minimum investment than ETIMX: RLBEX (250) vs ETIMX (100000). RLBEX annual gain was more profitable for investors over the last year : 10.30 vs. ETIMX (7.06). RLBEX return over 5 years is better than : 43.12 vs. ETIMX (39.06).
ETIMXRLBEXETIMX / RLBEX
Total Expense Ratio0.820.59139%
Annual Report Gross Expense Ratio0.890.59151%
Fund Existence10 years23 years-
Gain YTD7.79913.11359%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets389M262B0%
Annual Yield % from dividends2.031.79113%
Returns for 1 year7.0610.3069%
Returns for 3 years28.4242.2267%
Returns for 5 years39.0643.1291%
Returns for 10 years95.0180.03119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QNCX1.600.02
+1.27%
Quince Therapeutics
RGLD189.320.13
+0.07%
Royal Gold
RKDA3.48N/A
N/A
Arcadia Biosciences
EVTC33.44-0.77
-2.25%
EVERTEC
REPL5.73-0.28
-4.66%
Replimune Group